Shandong Oriental Ocean Sci-Tech (SHE:002086), through healthcare unit Oriental Ocean Life Science Technology, will establish a 4 million yuan joint venture with Dalian Zeruikang Trading, according to a Saturday filing on the Shenzhen Stock Exchange.
The planned venture, Liaoning Oriental Yinsheng Medical Technology, will manufacture medical devices, the filing said.
The Chinese seafood processor will hold 51% of the venture after injecting around 2.04 million yuan and Dalian Zeruikang Trading will own 49% of the venture after investing 1.96 million yuan into its capital.
Shandong Oriental's shares rose less than 3% at the close.
Price (RMB): ¥2.01, Change: ¥+0.050, Percent Change: +2.55%
Comments